
Shin Hon Chen
Examiner (ID: 706, Phone: (571)272-3789 , Office: P/2431 )
| Most Active Art Unit | 2431 |
| Art Unit(s) | 2131, 2431 |
| Total Applications | 1314 |
| Issued Applications | 1098 |
| Pending Applications | 88 |
| Abandoned Applications | 152 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18140941
[patent_doc_number] => 20230014782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => NEW SOLID STATE FORM OF LURBINECTEDIN
[patent_app_type] => utility
[patent_app_number] => 17/777985
[patent_app_country] => US
[patent_app_date] => 2020-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12178
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -68
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17777985
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/777985 | NEW SOLID STATE FORM OF LURBINECTEDIN | Nov 22, 2020 | Abandoned |
Array
(
[id] => 18147511
[patent_doc_number] => 20230021368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => PROCESS FOR THE PREPARATION OF CHLORANTRANILIPROLE
[patent_app_type] => utility
[patent_app_number] => 17/782807
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3057
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17782807
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/782807 | PROCESS FOR THE PREPARATION OF CHLORANTRANILIPROLE | Nov 18, 2020 | Abandoned |
Array
(
[id] => 16837794
[patent_doc_number] => 20210145806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => Methods of Treating Brain Cancer and Related Diagnostic Methods
[patent_app_type] => utility
[patent_app_number] => 16/952887
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4708
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16952887
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/952887 | Methods of Treating Brain Cancer and Related Diagnostic Methods | Nov 18, 2020 | Abandoned |
Array
(
[id] => 20622565
[patent_doc_number] => 12590062
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-31
[patent_title] => PD-1/PD-L1 inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/098171
[patent_app_country] => US
[patent_app_date] => 2020-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 158049
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098171
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/098171 | PD-1/PD-L1 INHIBITORS | Nov 12, 2020 | Issued |
Array
(
[id] => 16822584
[patent_doc_number] => 20210137877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => PRODUCTS AND METHODS FOR USING CANNABIDIOL IN COMBINATION WITH MELATONIN TO INDUCE SLEEP
[patent_app_type] => utility
[patent_app_number] => 17/091091
[patent_app_country] => US
[patent_app_date] => 2020-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6832
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17091091
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/091091 | PRODUCTS AND METHODS FOR USING CANNABIDIOL IN COMBINATION WITH MELATONIN TO INDUCE SLEEP | Nov 5, 2020 | Abandoned |
Array
(
[id] => 16655909
[patent_doc_number] => 20210052545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => COMPOSITIONS AND METHODS OF THEIR USE
[patent_app_type] => utility
[patent_app_number] => 17/085182
[patent_app_country] => US
[patent_app_date] => 2020-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22229
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17085182
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/085182 | COMPOSITIONS AND METHODS OF THEIR USE | Oct 29, 2020 | Pending |
Array
(
[id] => 16805968
[patent_doc_number] => 20210128521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => METHODS OF USING CANNABINOID COMPOSITIONS IN SPORTS MEDICINE APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 17/082915
[patent_app_country] => US
[patent_app_date] => 2020-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11531
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17082915
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/082915 | METHODS OF USING CANNABINOID COMPOSITIONS IN SPORTS MEDICINE APPLICATIONS | Oct 27, 2020 | Abandoned |
Array
(
[id] => 18091228
[patent_doc_number] => 20220409569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => Cannabinoid Products with High Bioavailability
[patent_app_type] => utility
[patent_app_number] => 17/772452
[patent_app_country] => US
[patent_app_date] => 2020-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6296
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17772452
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/772452 | Cannabinoid Products with High Bioavailability | Oct 26, 2020 | Pending |
Array
(
[id] => 19904089
[patent_doc_number] => 12281085
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-22
[patent_title] => Bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/077857
[patent_app_country] => US
[patent_app_date] => 2020-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11225
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17077857
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/077857 | Bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use thereof | Oct 21, 2020 | Issued |
Array
(
[id] => 18003391
[patent_doc_number] => 20220362157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => NEW HYDROCORTISONE HEMISUCCINATE LYOPHILIZATE
[patent_app_type] => utility
[patent_app_number] => 17/764584
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2604
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17764584
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/764584 | NEW HYDROCORTISONE HEMISUCCINATE LYOPHILIZATE | Oct 15, 2020 | Pending |
Array
(
[id] => 16760974
[patent_doc_number] => 20210106555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => PHYTOCANNABINOID FORMULATIONS AND METHODS FOR EXTRACTION
[patent_app_type] => utility
[patent_app_number] => 17/070047
[patent_app_country] => US
[patent_app_date] => 2020-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17070047
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/070047 | PHYTOCANNABINOID FORMULATIONS AND METHODS FOR EXTRACTION | Oct 13, 2020 | Abandoned |
Array
(
[id] => 18725702
[patent_doc_number] => 20230339880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => COMPOSITIONS OF AJULEMIC ACID AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/766638
[patent_app_country] => US
[patent_app_date] => 2020-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14349
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -53
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17766638
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/766638 | COMPOSITIONS OF AJULEMIC ACID AND USES THEREOF | Oct 8, 2020 | Abandoned |
Array
(
[id] => 17227199
[patent_doc_number] => 20210353755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => REDUCTION OF POST-SURGERY CANCER METASTASIS BY COMBINATION OF CANNABIDIOL AND NR2F6 INHIBITION
[patent_app_type] => utility
[patent_app_number] => 17/037284
[patent_app_country] => US
[patent_app_date] => 2020-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7976
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17037284
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/037284 | Reduction of post-surgery cancer metastasis by combination of cannabidiol and NR2F6 inhibition | Sep 28, 2020 | Issued |
Array
(
[id] => 17865336
[patent_doc_number] => 20220288071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => A SMALL MOLECULE THERAPEUTIC FOR PARKINSON'S DISEASE PAIRED WITH A BIOMARKER OF THERAPEUTIC ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/638676
[patent_app_country] => US
[patent_app_date] => 2020-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24142
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17638676
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/638676 | Small molecule therapeutic for parkinson's disease paired with a biomarker of therapeutic activity | Sep 3, 2020 | Issued |
Array
(
[id] => 18786060
[patent_doc_number] => 20230374030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => SOLID-STATE FORMS OF RELUGOLIX
[patent_app_type] => utility
[patent_app_number] => 17/597998
[patent_app_country] => US
[patent_app_date] => 2020-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5699
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17597998
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/597998 | SOLID-STATE FORMS OF RELUGOLIX | Jul 30, 2020 | Pending |
Array
(
[id] => 18018971
[patent_doc_number] => 20220370470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => METHYLTHIONINIUM FOR USE IN THE TREATMENT OF SYNAPTOPATHIES
[patent_app_type] => utility
[patent_app_number] => 17/620966
[patent_app_country] => US
[patent_app_date] => 2020-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10096
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17620966
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/620966 | METHYLTHIONINIUM FOR USE IN THE TREATMENT OF SYNAPTOPATHIES | Jun 28, 2020 | Abandoned |
Array
(
[id] => 17458643
[patent_doc_number] => 20220071947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => PHARMACEUTICAL APPLICATION OF DIMYRICETIN-BASED DISELENIDE
[patent_app_type] => utility
[patent_app_number] => 17/297913
[patent_app_country] => US
[patent_app_date] => 2020-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2444
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17297913
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/297913 | PHARMACEUTICAL APPLICATION OF DIMYRICETIN-BASED DISELENIDE | Jun 17, 2020 | Abandoned |
Array
(
[id] => 17472409
[patent_doc_number] => 20220079913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => DIHYDROMYRICETIN WITH ANTI-ALCOHOLIC EFFECT
[patent_app_type] => utility
[patent_app_number] => 17/290939
[patent_app_country] => US
[patent_app_date] => 2020-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2191
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17290939
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/290939 | DIHYDROMYRICETIN WITH ANTI-ALCOHOLIC EFFECT | Jun 17, 2020 | Abandoned |
Array
(
[id] => 17881058
[patent_doc_number] => 20220296535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => Antibacterial Dosage Regime Using Cannabinoids
[patent_app_type] => utility
[patent_app_number] => 17/617453
[patent_app_country] => US
[patent_app_date] => 2020-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27527
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17617453
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/617453 | Antibacterial Dosage Regime Using Cannabinoids | Jun 16, 2020 | Abandoned |
Array
(
[id] => 17761414
[patent_doc_number] => 20220235026
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => TRIAZOLE CARBOXYLIC ACIDS AS LPA ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 17/617322
[patent_app_country] => US
[patent_app_date] => 2020-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46164
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17617322
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/617322 | Triazole carboxylic acids as LPA antagonists | Jun 15, 2020 | Issued |